Pharmaceutical Business review

NovaBay closes IPO

NovaBay has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering (IPO) price to cover over-allotments, if any.

Dundee Securities acted as the sole book runner for the IPO, with Desjardins Securities as co-lead manager. The shares were offered in Canada by an underwriting syndicate co-led by Dundee Securities, Desjardins Securities and Blackmont Capital and in the US by Dundee Securities and Dawson James Securities.